Related Experiment Video
Updated: Jun 24, 2026

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
Published on: October 7, 2025
MicroRNA-based therapeutics for cancer
1Department of Pathology, Evanston Northwestern Hospital, Evanston, Illinois, USA.
Abstract:
MicroRNAs (miRNAs) are non-protein-coding small RNA molecules that negatively regulate target messenger RNA through degradation or suppression of protein translation. MiRNAs play important roles in the control of many biologic processes, such as development, differentiation, proliferation, and apoptosis. Increasing evidence shows that aberrant miRNA expression profiles and unique miRNA signaling pathways are present in a variety of cancers. MiRNAs function as oncogenes or tumor suppressors during tumor development and progression. Experimental evidence demonstrates that correction of specific miRNA alterations using miRNA mimics or antagomirs can normalize the gene regulatory network and signaling pathways, and reverse the phenotype in cancerous cells. MiRNA-based gene therapy provides an attractive anti-tumor approach for integrated cancer therapy. In this review, we focus on miRNA-based treatment for cancers, summarize the delivery systems used in experimental and preclinical research, such as liposomes, viral vectors, and nanoparticles, and consider the safety and toxicity of miRNA therapy.
Insights
MicroRNAs (miRNAs) regulate gene expression and are implicated in cancer. miRNA-based therapies, using mimics or antagomirs delivered via nanoparticles, offer a promising anti-tumor strategy with considerations for safety and toxicity.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- MicroRNAs (miRNAs) are small, non-coding RNA molecules regulating gene expression post-transcriptionally.
- Aberrant miRNA expression is linked to various cancers, where miRNAs can act as oncogenes or tumor suppressors.
- MiRNAs are crucial in regulating fundamental biological processes including cell development, differentiation, proliferation, and apoptosis.
Purpose of the Study:
- To review miRNA-based therapeutic strategies for cancer treatment.
- To summarize the various delivery systems employed for miRNA therapeutics in preclinical and experimental research.
- To discuss the safety and toxicity profiles associated with miRNA-based cancer therapies.
Main Methods:
- Review of existing literature on miRNA function in cancer.
- Analysis of experimental and preclinical studies utilizing miRNA mimics and antagomirs.
- Examination of diverse delivery systems including liposomes, viral vectors, and nanoparticles.
Main Results:
- Correction of aberrant miRNA expression can restore normal gene regulatory networks and reverse cancer cell phenotypes.
- MiRNA mimics and antagomirs demonstrate potential in normalizing dysregulated signaling pathways in cancer.
- Various delivery systems are being explored to effectively and safely administer miRNA therapeutics.
Conclusions:
- MiRNA-based gene therapy presents a viable and attractive approach for integrated cancer treatment.
- Further research into delivery systems and safety is essential for clinical translation of miRNA therapies.
- Modulating miRNA activity offers a novel strategy to combat cancer by targeting key oncogenic or tumor-suppressive pathways.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Microorganisms in Medicine and Therapeutics

